New Pharmacy Models, Burgeoning Array of Brands Dominate CVS Investor Day

Hosting its first analyst-focused event in two years, CVS Health Corp. made a splash on Dec. 5 by introducing a pair of new drug reimbursement models, detailing its long-term margin improvement goals, and rebranding its health services segment.

Although the new pharmacy models captured the most headlines, Wall Street analysts also appeared cautiously impressed with the overall picture that CVS painted — depicting a company with ambitious goals to best its rivals in the health benefits, retail pharmacy, care delivery and health services sectors by getting its many moving parts to work together.

0 Comments
© 2024 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

cigna-phone
November 22

Express Scripts’ Mark Cuban-Inspired Pricing Model Stokes Skepticism, Intrigue

READ MORE
cvs-health-building
November 3

CVS Reports Strong Overall 3Q Results Despite High MA Utilization

READ MORE
cvs-pharmacy-sign
September 1

CVS Launches New Biosimilar White Label, But Can it Bring Down Costs?

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today